Even at $28,000 more, the health care system says it represents a good value.

They will pay $385 million for rights for an experimental oral diabetes medication from OSI Pharmaceuticals Inc. of Melville.

How will the U.S. pay for future health care needs?

Young children who load up on sugary soft drinks risk developing signs of heart disease and diabetes in adolescence, according to a long-term study in which doctors followed a group of girls from 5 to 13 years of age.

Increasing the intake of the soluble fiber beta-glucan decreased the glucose and insulin response in overweight men, and could help reduce the risk of diabetes.

Women who regularly consumed at least one serving of full-fat diary every day gained about 30 per cent less weight than women who didn’t, says a study from Sweden .

After all the problems we have had in the past with weight-loss drugs, the scientific community is asking for longer-term studies to address the safety concerns.

A new study suggests that eye injections of the drug Lucentis (also known as ranibizumab) appear to be useful in the treatment of a potentially blinding eye condition called macular edema that can afflict people with diabetes.

Duloxetine was linked with modest changes in glycemia in patients with diabetic peripheral neuropathic pain (DPNP), according to the results of 3 randomized trials.

First study to examine the mechanism(s) by which the addition of rosiglitazone or bedtime glargine insulin improves glucose homeostasis in poorly controlled Type 2 patients on metformin plus a sulfonylurea.